Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 130

Similar articles for PubMed (Select 10950895)

1.

Asthma exacerbations during long term beta agonist use: influence of beta(2) adrenoceptor polymorphism.

Taylor DR, Drazen JM, Herbison GP, Yandava CN, Hancox RJ, Town GI.

Thorax. 2000 Sep;55(9):762-7.

2.

Effect of beta2-adrenergic receptor polymorphism on response to longacting beta2 agonist in asthma (LARGE trial): a genotype-stratified, randomised, placebo-controlled, crossover trial.

Wechsler ME, Kunselman SJ, Chinchilli VM, Bleecker E, Boushey HA, Calhoun WJ, Ameredes BT, Castro M, Craig TJ, Denlinger L, Fahy JV, Jarjour N, Kazani S, Kim S, Kraft M, Lazarus SC, Lemanske RF Jr, Markezich A, Martin RJ, Permaul P, Peters SP, Ramsdell J, Sorkness CA, Sutherland ER, Szefler SJ, Walter MJ, Wasserman SI, Israel E; National Heart, Lung and Blood Institute's Asthma Clinical Research Network.

Lancet. 2009 Nov 21;374(9703):1754-64. doi: 10.1016/S0140-6736(09)61492-6.

3.

Salmeterol response is not affected by beta2-adrenergic receptor genotype in subjects with persistent asthma.

Bleecker ER, Yancey SW, Baitinger LA, Edwards LD, Klotsman M, Anderson WH, Dorinsky PM.

J Allergy Clin Immunol. 2006 Oct;118(4):809-16. Epub 2006 Aug 28.

PMID:
17030231
4.

Beta2-receptor polymorphisms in patients receiving salmeterol with or without fluticasone propionate.

Bleecker ER, Nelson HS, Kraft M, Corren J, Meyers DA, Yancey SW, Anderson WH, Emmett AH, Ortega HG.

Am J Respir Crit Care Med. 2010 Apr 1;181(7):676-87. doi: 10.1164/200809-1511OC. Epub 2009 Nov 12.

PMID:
19910613
5.

Beta2-adrenergic receptor polymorphisms affect response to treatment in children with severe asthma exacerbations.

Carroll CL, Stoltz P, Schramm CM, Zucker AR.

Chest. 2009 May;135(5):1186-92. doi: 10.1378/chest.08-2041. Epub 2008 Nov 24.

PMID:
19029431
6.

Adrenergic beta(2)-receptor genotype predisposes to exacerbations in steroid-treated asthmatic patients taking frequent albuterol or salmeterol.

Basu K, Palmer CN, Tavendale R, Lipworth BJ, Mukhopadhyay S.

J Allergy Clin Immunol. 2009 Dec;124(6):1188-94.e3. doi: 10.1016/j.jaci.2009.07.043. Epub .

PMID:
19800676
7.

The influence of polymorphism at position 16 of the beta2-adrenoceptor on the development of tolerance to beta-agonist.

Taylor DR, Hancox RJ, McRae W, Cowan JO, Flannery EM, McLachlan CR, Herbison GP.

J Asthma. 2000 Dec;37(8):691-700.

PMID:
11192234
8.

Arginine-16 beta2 adrenoceptor genotype predisposes to exacerbations in young asthmatics taking regular salmeterol.

Palmer CN, Lipworth BJ, Lee S, Ismail T, Macgregor DF, Mukhopadhyay S.

Thorax. 2006 Nov;61(11):940-4. Epub 2006 Jun 13.

9.

Asthma control during long-term treatment with regular inhaled salbutamol and salmeterol.

Taylor DR, Town GI, Herbison GP, Boothman-Burrell D, Flannery EM, Hancox B, Harré E, Laubscher K, Linscott V, Ramsay CM, Richards G.

Thorax. 1998 Sep;53(9):744-52. Erratum in: Thorax 1999 Feb;54(2):188.

10.

Acute and chronic lung function responses to salmeterol and salmeterol plus fluticasone propionate in relation to Arg16Gly beta(2)-adrenergic polymorphisms.

Yancey SW, Klotsman M, Ortega HG, Edwards LD, Anderson WH.

Curr Med Res Opin. 2009 Apr;25(4):1011-8. doi: 10.1185/03007990902805981 .

PMID:
19275519
11.
12.

Combined salmeterol/fluticasone propionate versus fluticasone propionate alone in mild asthma : a placebo-controlled comparison.

Boonsawat W, Goryachkina L, Jacques L, Frith L.

Clin Drug Investig. 2008;28(2):101-11.

PMID:
18211118
13.

Polymorphism of the ADRB2 gene and response to inhaled beta- agonists in children with asthma: a meta-analysis.

Finkelstein Y, Bournissen FG, Hutson JR, Shannon M.

J Asthma. 2009 Nov;46(9):900-5. doi: 10.3109/02770900903199961.

PMID:
19905915
15.

Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomised, placebo-controlled cross-over trial.

Israel E, Chinchilli VM, Ford JG, Boushey HA, Cherniack R, Craig TJ, Deykin A, Fagan JK, Fahy JV, Fish J, Kraft M, Kunselman SJ, Lazarus SC, Lemanske RF Jr, Liggett SB, Martin RJ, Mitra N, Peters SP, Silverman E, Sorkness CA, Szefler SJ, Wechsler ME, Weiss ST, Drazen JM; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network.

Lancet. 2004 Oct 23-29;364(9444):1505-12.

PMID:
15500895
16.

[The role of beta 2-adrenoceptor gene polymorphisms in asthma].

Sato R.

Hokkaido Igaku Zasshi. 2000 Mar;75(2):81-94. Japanese.

PMID:
10791249
17.

Effect of polymorphism of the beta(2)-adrenergic receptor on response to regular use of albuterol in asthma.

Israel E, Drazen JM, Liggett SB, Boushey HA, Cherniack RM, Chinchilli VM, Cooper DM, Fahy JV, Fish JE, Ford JG, Kraft M, Kunselman S, Lazarus SC, Lemanske RF Jr, Martin RJ, McLean DE, Peters SP, Silverman EK, Sorkness CA, Szefler SJ, Weiss ST, Yandava CN; National Heart, Lung, and Blood Institute's Asthma Clinical Research Network.

Int Arch Allergy Immunol. 2001 Jan-Mar;124(1-3):183-6. Erratum in: Int Arch Allergy Immunol. 2012 Feb;157(2):212.

PMID:
11306963
18.

Lung function response to 12-week treatment with combined inhalation of long-acting beta2 agonist and glucocorticoid according to ADRB2 polymorphism in patients with chronic obstructive pulmonary disease.

Kim WJ, Oh YM, Sung J, Kim TH, Huh JW, Jung H, Lee JH, Kim EK, Lee JH, Lee SM, Lee S, Lim SY, Shin TR, Yoon HI, Kwon SY, Lee SD.

Lung. 2008 Nov-Dec;186(6):381-6. doi: 10.1007/s00408-008-9103-9. Epub 2008 Aug 29.

PMID:
18758858
19.

Influence of β(2)-adrenergic receptor polymorphisms on asthma exacerbation in children with severe asthma regularly receiving salmeterol.

Giubergia V, Gravina L, Castaños C, Chertkoff L.

Ann Allergy Asthma Immunol. 2013 Mar;110(3):156-60. doi: 10.1016/j.anai.2012.12.018. Epub 2013 Jan 23.

PMID:
23548523
20.
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk